Supplementary Materials: Anti-RNA Polymerase III Antibodies in Systemic Sclerosis Are Not Associated with Subsequent Increased Malignancy Risk: A Retrospective TriNetX Cohort Study
Published: 10 August 2026| Version 1 | DOI: 10.17632/6mw7fg7rhr.1
Contributors:
Sydney McDaniel, , , Description
Supplementary materials for Anti-RNA Polymerase III Antibodies in Systemic Sclerosis Are Not Associated with Subsequent Increased Malignancy Risk: A Retrospective TriNetX Cohort Study. Supplementary Material I: Outcomes of Interest by International Classification of Diseases, 10th Revision Supplementary Material II: Average Anti-RNA Polymerase III Antibody Levels in Cohort 1
Files
Institutions
- The University of Texas Medical Branch at GalvestonTexas, Galveston
Categories
Cancer, Scleroderma